Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies
- 1 November 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 376 (3) , 605-610
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Galectin-3: Presurgical marker of thyroid follicular epithelial cell-derived carcinomasJournal of Endocrinological Investigation, 2004
- Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesionsThe Lancet, 2001
- Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinomaCancer, 2000
- Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasmsCancer, 1999
- Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colonCancer, 1995
- Galectin-3 Is a Novel Substrate for Human Matrix Metalloproteinases-2 and -9Biochemistry, 1994
- Monoclonal Antibody against PRADl/Cyclin Dl Stains Nuclei of Tumor Cells with Translocation or Amplification at BCL‐1 LocusJapanese Journal of Cancer Research, 1994
- Structure-function relationship of a recombinant human galactoside-binding proteinBiochemistry, 1993
- Fine-Needle Aspiration Biopsy of the Thyroid: An AppraisalAnnals of Internal Medicine, 1993
- Preparation of Monomeric Fab'‐Horseradish Peroxidase Conjugate Using Thiol Groups in the Hinge and Its Evaluation in Enzyme Immunoassay and Immunohistochemical Staining. aAnnals of the New York Academy of Sciences, 1983